/-/media/corpsite/assets/park-life/news-and-events/news/logo/hkstp_logo_en_op-dark-mode.svg?mw=1980&rev=578e4e3c3c8a43ae96060191588e8ecc&hash=CDDFB54416A7577AAA399A746252CD83

Company

AI OF EYE LIMITED is a Hong Kong MedTech company building AI for eyecare and preventive health screening. Founded by a cross-disciplinary team from The Hong Kong Polytechnic University ecosystem, the company combines computer vision, medical image analysis, ophthalmic workflow design, and commercialisation experience. The AIOFEYE team has accumulated high-quality research publications, software registrations/copyrights, and patent assets, and has received recognition from innovation and entrepreneurship competitions as well as the HKSTP Micro Fund. AIOFEYE aims to make professional eye-health screening more accessible, standardised, and affordable for hospitals, primary care institutions, community screening programmes, and optical-service providers.

Description

AIOFEYE is an AI-powered eye examination and multi-disease screening system for early eye-health management. It analyses fundus, ocular-surface, and OCT images to support image quality control, diabetic retinopathy and glaucoma grading, vessel and lesion analysis, cup-disc segmentation, and standardised reports for hospitals, primary care, screening partners, and optical-service providers.

Our Beliefs

We believe eye care should be accessible, preventive and data-driven. Many vision-threatening diseases can be controlled more effectively when they are detected early, yet specialist resources are limited and unevenly distributed. AIOFEYE’s belief is “AI for eyecare, AI for everyone”: use trustworthy medical AI to bring standardised eye screening, report generation and follow-up guidance from specialist settings to communities, primary care and everyday health services.

Product

AI OF EYE LIMITEDProductImg18d485792-715a-f111-a825-00224858ee6b_ProductImage1_25062026
AI OF EYE LIMITEDProductImg28d485792-715a-f111-a825-00224858ee6b_ProductImage2_25062026
AI OF EYE LIMITEDProductImg38d485792-715a-f111-a825-00224858ee6b_ProductImage3_25062026
AIOFEYE is a software platform for AI-assisted eye examination and multi-disease early screening. Users upload or connect images from fundus cameras, slit-lamp systems, and OCT devices; the system then performs quality assessment, low-quality image enhancement, retinal vessel analysis, lesion detection, optic cup/disc segmentation, diabetic retinopathy grading, glaucoma grading, macular/retinal abnormality analysis, and corneal epithelial defect quantification. The platform generates standardised visual reports within minutes and supports both cloud-based and offline deployment, enabling medical staff and screening partners to improve efficiency, consistency, and accessibility. AIOFEYE is designed for hospitals, primary care clinics, community screening programmes, health-check centres, optical-service chains, pharmacies, insurers, and government/public-health projects.

Technology

AIOFEYE integrates multimodal ophthalmic image AI with cloud and offline screening software. The core technology includes Uni4Eye for unified ophthalmic image understanding, I-SECRET for fundus image quality enhancement, COROLLA for multimodal glaucoma grading, JOINED for optic-disc/cup and macular localisation, AADG for retinal vessel segmentation, and corneal epithelial defect segmentation/quantification algorithms. The service connects with fundus cameras, slit lamps, and OCT devices, performs image quality control, disease grading, lesion and vessel analysis, and produces visualised reports. It can be deployed for hospital triage, community screening, health-check centres, optical shops, pharmacies, insurance/enterprise wellness partners, and government population screening projects.